GSA CAPITAL PARTNERS LLP - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 112 filers reported holding ALBIREO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q2 2022$200,000
-58.7%
10,079
-51.5%
0.03%
-50.8%
Q4 2021$484,000
+29.4%
20,782
+73.6%
0.06%
+60.5%
Q3 2021$374,000
+65.5%
11,973
-13.2%
0.04%
-33.3%
Q1 2020$226,00013,7870.06%
Other shareholders
ALBIREO PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Prosight Management, LP 514,082$11,973,0007.17%
Privium Fund Management B.V. 379,117$8,959,0001.78%
Birchview Capital, LP 113,000$2,632,0001.70%
Sio Capital Management, LLC 213,913$4,982,0001.50%
Perceptive Advisors 4,720,278$109,936,0000.85%
Chicago Capital, LLC 849,239$19,779,0000.74%
APOGEM CAPITAL LLC 38,601$899,0000.59%
Samsara BioCapital, LLC 100,000$2,329,0000.45%
Artal Group S.A. 600,000$13,974,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 458,011$10,667,0000.38%
View complete list of ALBIREO PHARMA INC shareholders